title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Neurocrine Biosciences  ( NBIX )  Earnings Expected to Grow: What to Know Ahead of Next Week's Release,20230426T140234,https://www.zacks.com/stock/news/2085001/neurocrine-biosciences-nbix-earnings-expected-to-grow-what-to-know-ahead-of-next-weeks-release,NBIX,0.088309,Neutral,0.116764
Alkermes Issues Letter to Shareholders Highlighting Skills and Experience of Refreshed Board of Directors - Alkermes  ( NASDAQ:ALKS ) ,20230613T110000,https://www.benzinga.com/pressreleases/23/06/n32831446/alkermes-issues-letter-to-shareholders-highlighting-skills-and-experience-of-refreshed-board-of-di,NBIX,0.028649,Neutral,0.027306
"Biotech Daily: Amgen, Gilead Go Shopping, Nod For AstraZeneca's Lynparza In Early Stage Breast Cancer, Decision Day For Alzheimer's Associated Hallucinations Candidate",20220804T130628,https://www.benzinga.com/general/biotech/22/08/28353376/biotech-daily-amgen-gilead-go-shopping-nod-for-astrazenecas-lynparza-in-early-stage-breast-cancer,NBIX,0.09989,Neutral,0.0
"Congenital Adrenal Hyperplasia Treatment Drug Market to Exhibit Immense Growth During the Study Period  ( 2019-2032 ) , Predicts DelveInsight",20231221T220100,https://www.prnewswire.com/news-releases/congenital-adrenal-hyperplasia-treatment-drug-market-to-exhibit-immense-growth-during-the-study-period-20192032-predicts-delveinsight-302020741.html,NBIX,0.055946,Neutral,0.093941
"GoDaddy To Rally Around 44%? Here Are 10 Other Analyst Forecasts For Wednesday - C.H. Robinson Worldwide  ( NASDAQ:CHRW ) , Casey's General Stores  ( NASDAQ:CASY ) ",20230913T124525,https://www.benzinga.com/news/23/09/34534477/godaddy-to-rally-around-44-here-are-10-other-analyst-forecasts-for-wednesday,NBIX,0.265859,Somewhat-Bullish,0.272509
"Heska To $165? Plus BTIG Cuts PT On This Stock By 67% - CytomX Therapeutics  ( NASDAQ:CTMX ) , Elanco Animal Health  ( NYSE:ELAN ) ",20221114T132114,https://www.benzinga.com/news/22/11/29699762/heska-to-165-plus-btig-cuts-pt-on-this-stock-by-67,NBIX,0.491878,Somewhat-Bearish,-0.328278
Neurocrine Biosciences  ( NBIX )  Q3 Earnings Miss Estimates,20241030T121014,https://www.zacks.com/stock/news/2360311/neurocrine-biosciences-nbix-q3-earnings-miss-estimates,NBIX,0.142144,Neutral,0.119122
"Earnings Scheduled For May 4, 2022",20220504T083630,https://www.benzinga.com/news/earnings/22/05/26983503/earnings-scheduled-for-may-4-2022,NBIX,0.010898,Neutral,0.000234
